Maarten Kraan

Maarten Kraan

Company: AM-Pharma

Job title: Chief Medical Officer

Seminars:

Panel Discussion: How Can We Invigorate AKI Drug Development? Identifying Novel Targets & Establishing a Pathway to Surmount Challenges in Biomarkers & Precision Medicine 2:30 pm

What can we learn from clinical setbacks in AKI? Addressing translational barriers in AKI: optimizing models to predict efficacy and biomarkers of therapeutic target engagement Characterizing endophenotypes through omics approaches to enable comprehensive, longitudinal understanding of AKIRead more

day: Seminar Day

What Does Smarter Clinical Trial Design & Better Readouts Look Like for AKI? 2:00 pm

What have we learned from clinical setbacks? Reviewing serum creatinine and hard endpoints for AKI Selecting novel biomarkers to monitor disease progression and therapeutic efficacyRead more

day: Seminar Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.